The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Not yet recruiting · NCT07386002 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07386002 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| T-MAXIMUM Pharmaceutical Inc | 1 |
| Virginia Contract Research Organization Co., Ltd. | 5 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital, Kaohsiung | Kaohsiung City | Taiwan | 1 |
| Chang Gung Memorial Hospital, Linkou | Taoyuan | Taiwan | 1 |
| Hualien Tzu Chi Hospital | Hualien City | Taiwan | 2 |
| The Johns Hopkins Sidney Kimmel Cancer Center | Baltimore | United States | 1 |